In This Section

Program: Saturday, September 20

Wednesday, Sept. 17Thursday, Sept. 18Friday, Sept. 19Sunday, Sept. 21

Saturday, September 20

Saturday, September 20

BREAKFAST/Networking roundtables

8-9 a.m. | Key Ballroom 3, 4, 6

Plenary Session 3: Bridging the Gap between Genomics and Social Determinants

9-10:30 a.m.

Session Chair: Christopher R. Flowers, UT MD Anderson Cancer Center, Houston, Texas

  • Melissa B. Davis, Morehouse School of Medicine, Atlanta, Georgia
  • 9:25 a.m. | Biomarkers of health disparities: LRIG1 as a therapeutic target in breast cancer
    Brittany D. Jenkins-Lord, Johns Hopkins Bloomberg Sch. of Public Health, Baltimore, Maryland
  • 9:45 a.m. | Health disparities in diffuse large B-cell lymphoma
    Michelle J. Lee, Emory University School of Medicine, Atlanta, Georgia
  • 10:05 a.m. | Panel Discussion/Q&A

break

10:30-11 a.m. | Key Ballroom Foyer

Concurrent sessions 5 and 6 

11 a.m.-12 p.m.

Concurrent Session 5: The Science of Community Engagement: Fostering Resilience and Sustaining Impact (Companion Session to Plenary 1)

11 a.m.-12 p.m. | Key Ballroom 7-12

Session Chair:  Laura Crandon, TOCH4LIFE, INC., Clarksville, Maryland

  • 11:05 a.m. | Kemith Calvin, Ebenezer AME Church, Fort Washington, Maryland
  • 11:15 a.m. | Educating community leaders in cancer education and awareness: Direct engagement between Black cancer survivors and cancer center leaders
    Kimberly Richardson, Black Cancer Collaborative, Chicago, Illinois
  • 11:25 a.m. | Celina Valencia, University of Arizona Cancer Center, Tucson, Arizona
  • 11:35 a.m. | Latina cancer survivors developing resilience then impacting their communities
    Ivis C. Febus-Sampayo, Disrupt Project, Winter Garden, Florida
  • 11:45 a.m. | Panel Discussion/Q&A

Concurrent Session 6: Innovative Approaches for Continued Progress in Low-Resource Settings

11 a.m.-12 p.m. | Holiday Ballroom 1-3

Session Chair: Olufunmilayo I. Olopade, UChicago Medicine Comprehensive Cancer Ctr., Chicago, Illinois

  • 11:05 a.m. | Harnessing our common African genomes to improve health globally
    Ambroise Wonkam, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • 11:15 a.m. | Team science unlocks underused molecular big data for scalable innovation in cancer research
    Long Nguyen, University of Chicago, Chicago, Illinois
  • 11:25 a.m. | How can public health systems facilitate access to timely, high-quality cancer care for rural Americans?
    Jason Semprini, Des Moines University, West Des Moines, Iowa
  • 11:35 a.m. | Point-of-care ultrasound guidance for cervical cancer brachytherapy: A scalable innovation in low-resource settings
    Onyinye D. Balogun, Weill Cornell Medicine, Brooklyn, New York
  • 11:45 a.m. | Panel Discussion/Q&A

lunch on own

12-2 p.m.

Robert A. Winn Excellence in Clinical Trials: Career Development Award

12-12:30 p.m. | Holiday Ballroom 1-3

  • 12 p.m. | Joy L. Jones, Executive Director, Robert A. Winn Excellence in Clinical Trials Award Program, VCU Massey Comprehensive Cancer Center, Richmond, Virginia
  • 12:10 p.m. | Megan Becker, Executive Director, Winn Career Development Awards Program, VCU Massey Comprehensive Cancer Center, Richmond, Virginia
  • 12:20 p.m. | Panel Discussion/Q&A

Concurrent Sessions 7 and 8

2-3 p.m.

Concurrent Session 7: Charting the Path Forward: Supporting Early-Stage Investigators (Companion Session to Plenary 1)

2-3 p.m. | Key Ballroom 7-12

Session Chair: Shine Chang, UT MD Anderson Cancer Center, Houston, Texas

  • 2:03 p.m. | Supporting targeted trainees and junior faculty in a time of extreme threat
    Ash Alpert, Yale Cancer Center, New Haven, Connecticut
  • 2:13 p.m. | Charting the path for funding success as an early career cancer researcher
    Nastaran Zahir, National Cancer Institute-Shady Grove Campus, Rockville, Maryland
  • 2:23 p.m. | Navigating icebergs: Building resilience in the face of challenges
    Bernard Fuemmeler, Virginia Commonwealth University, Richmond, Virginia
  • 2:40 p.m. | Panel Discussion/Q&A

Concurrent Session 8: Advancing Cancer Control in Persistent Poverty Areas: Scalable Strategies for Lasting Impact

2-3 p.m. | Holiday Ballroom 1-3

Session Chair: Shobha Srinivasan, NCI-Division of Cancer Control and Population Sciences, Rockville, Maryland and Rulla M. Tamimi, Weill Cornell Medicine, New York, New York

  • 2:05 p.m. | Cancer risk education in schools for youth and families: The (CARES4You) Study
    Erica Phillips, Weill Cornell Medicine, New York, New York
    Jared Fox, Fox EduConsulting, Washington, D.C.
  • 2:20 p.m. | Community-led scale out of Turtle Island Tales: A health promotion program for Native American families with young children
    Emily J. Tomayko, Montana State University, Bozeman, Montana
    Olivia Davis, Oregon State University, Corvallis, Oregon
  • 2:35 p.m. | How the “poverty-industrial complex” contributes to persistent poverty
    Anne S. Kim, Washington Monthly, Washington, D.C.
  • 2:50 p.m. | Panel Discussion/Q&A

BREAK

3-3:15 p.m.

Concurrent Sessions 9 and 10

3:15-4:15 p.m.

Concurrent Session 9: Funding Cancer Health Disparities Research: Insights from Foundations and Industry (Companion Session to Plenary 1)

3:15-4:15 p.m. | Key Ballroom 7-12

Session Chair: Joanne W. Elena, American Cancer Society, Kennesaw, Georgia and Yixian (John) Zhang, American Association for Cancer Research, Philadelphia

  • 3:18 p.m. | Opportunities for research funding at the American Cancer Society
    Joanne W. Elena, American Cancer Society, Kennesaw, Georgia
  • 3:26 p.m. | Stand Up To Cancer’s model for supporting impactful cancer research
    Catherine L. Higgins, Stand Up To Cancer, Los Angeles, California
  • 3:34 p.m. | Title to be announced
    Christina (Leah) Kline, American Association for Cancer Research, Philadelphia, Pennsylvania
  • 3:42 p.m. | Title to be announce
    Sabrina Lynn Meyers, Gilead Sciences, Inc., Chicago, Illinois
  • 3:50 p.m. | Panel Discussion/Q&A

Concurrent Session 10: Inflammation and Comorbidities

Session Chair: Electra D. Paskett, The Ohio State University, Columbus, Ohio

  • 3:20 p.m. | Inflammation, comorbidities, and stress signaling as contributors to the US prostate cancer outcome disparity
    Stefan Ambs, National Cancer Institute, Bethesda, Maryland
  • 3:30 p.m. | Comorbidities, inflammation, tumor environment, and disparities among breast and ovarian cancer patients
    Lindsay J. Collin, Emory University, Rollins School of Public Health, Atlanta, Georgia
  • 3:40 p.m. | Adana A. M. Llanos, Columbia University Mailman School of Public Health, New York, New York
  • 3:50 p.m. | The power of laughter to reduce stress, inflammation, and comorbidities
    Saranne Rothberg, The Comedy Cures Foundation, Tenafly, New Jersey
  • 4 p.m. | Panel Discussion/Q&A

break

4:15-4:30 p.m.

Special Session: Advances in Clinical Trial Access and Community Engagement

Session organized by Stand Up To Cancer (SU2C)

4:30-5:45 p.m. | Key Ballroom 7-12

Session Chair: William G. Nelson, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland

  • 4:35 p.m. | DISRUPTing how we recruit to cancer clinical trials
    Nina Bickell, Icahn School of Medicine at Mount Sinai, New York, New York
  • 4:45 p.m. | Building the foundation to address disparities in clinical research: Lessons learned from the ADACT Project
    Linda Fleisher, Fox Chase Cancer Center, Philadelphia, Pennsylvania
  • 4:55 p.m. | Planes, trains, and clinical trials: Moving patients to move science  
    Sukh Makhnoon, UT Southwestern Medical Center, Dallas, Texas
  • 5:05 p.m. | Eliminating enrollment barriers to early phase trials across communities in Los Angeles
    Jennifer Tsui, USC – University of Southern California, Los Angeles, California
  • 5:15 p.m. | Vernal H. Branch, Virginia Breast Cancer Foundation, Mooresville, North Carolina
  • 5:20 p.m. | Panel Discussion/Q&A

Lightning lectures 2

5:45-6:15 p.m. | Key Ballroom 7-12

Session Chair: Yamile Molina, University of Illinois at Chicago, Chicago, Illinois

  • 5:48 p.m. | The SGM Cancer CARE Workshop: A conversation on the importance of providing training, mentoring and networking to address cancer disparities for underserved populations in the face of changing federal priorities*
    Shine Chang, The The University of Texas MD Anderson Cancer Center, Houston, Texas
  • 5:51 p.m. | Genetic ancestry in Colombian men with suspected prostate cancer and its association with novel early detection biomarkers*
    Dayanne M. Rodríguez Hernández, Instituto Nacional de Cancerología, Bogotá, Colombia
  • 5:54 p.m. | Feasibility of an interventional clinical trial addressing prostate cancer disparities in Black men by decentralization (DCT): A potential solution to disparities in clinical trial participation*
    Kim M. Barbel Johnson, Mayo Clinic, Jacksonville, Florida
  • 5:57 p.m. | Germline pathogenic variant profiling of DNA double-strand break repair pathways in populations with African and European genetic ancestry*
    Musinu Zakari, Fox Chase Cancer Center, Philadelphia, Pennsylvania
  • 6 p.m. | Breast tumor methylation landscape by estrogen receptor status and race using an NGS Methylation Detection System*
    Jasmine M. Miller-Kleinhenz, University of Mississippi Medical Center, Jackson, Mississippi
  • 6:03 p.m. | Health disparities by sex and cancer type among suicide decedents*
    Brandy M. Byrwa-Hill, University of Utah Huntsman Cancer Institute, Salt Lake City, Utah
  • 6:06 p.m. | Expanding clinical trial offerings to veterans: A modified ethnographic approach to document and analyze forming a research partnership between an academic cancer center and a veterans affairs medical center*
    Heather McKee Hurwitz, Cleveland Clinic Cancer Institute, Cleveland, Ohio
  • 6:09 p.m. | Cancer outreach and community engagement through a collaboration with a federally qualified health center: Promoting cancer screening recommendations for Native Hawaiian and Pacific Islanders in Hawai’i*
    Mark L. Willingham Jr., University of Hawaiʻi Cancer Center, Honolulu, Hawaii

poster session c and reception

6:15-7:45 p.m. | Key Ballroom 1-6

Wednesday, Sept. 17Thursday, Sept. 18Friday, Sept. 19Sunday, Sept. 21